Ambrisentan, also known by its brand name Letairis, is a medication used for pulmonary arterial hypertension (PAH), or high blood pressure in the blood vessels of the lungs. This medication is available as a lower-cost generic. The usual dose is one tablet daily. Ambrisentan (Letairis) is generally well-tolerated, though the most common side effect is swelling in the arms or legs. It also has a risk of causing severe and life-threatening harm to unborn babies, so the medication is only available through the Ambrisentan REMS program for people who can get pregnant.
Ambrisentan (Letairis) is an endothelin receptor antagonist. It works by blocking the effects of a protein called endothelin. Doing so relaxes the blood vessels that go from your heart to your lungs and allows more blood to flow through. This lowers the amount of work your heart needs to pump blood to your lungs to get oxygen for your body. As a result, it's easier for you to exercise and breathe.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
More common
Bloating or swelling of the face, arms, hands, lower legs, or feet
rapid weight gain
tingling of the hands or feet
unusual weight gain or loss
Less common
fast, irregular, pounding, or racing heartbeat or pulse
headache
muscle aches
pain or tenderness around the eyes and cheekbones
stuffy or runny nose
tightness of the chest
trouble breathing
unusual tiredness or weakness
Incidence not known
clay colored stools
dark urine
decrease in the amount of urine
decreased appetite
dilated neck veins
extreme tiredness or weakness
irregular breathing
large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals
loss of appetite
noisy, rattling breathing
pale skin
skin rash, itching
stomach pain or tenderness
troubled breathing at rest
troubled breathing with exertion
vomiting
yellow skin or eyes
Get emergency help immediately if any of the following symptoms of overdose occur:
Symptoms of overdose
Blurred vision
confusion
dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
sweating
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
Difficulty having a bowel movement
feeling of warmth
redness of the face, neck, arms, and occasionally, upper chest
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
In clinical studies, some people started to see improvement in their walking distance and ability to exercise within 1 month of starting ambrisentan (Letairis). But the studies also reported that people had the most benefit from the medication after they took it for 3 months. Check in with your provider regularly to discuss how well your treatment with ambrisentan (Letairis) is doing to help improve your ability to exercise.
No, avoid taking ambrisentan (Letairis) during pregnancy. This medication can cause severe and life-threatening harm to unborn babies based on findings from animal studies. For this reason, you must enroll in the Risk Evaluation and Mitigation Strategy (REMS) program called the Ambrisentan REMS program if you're able to get pregnant. To avoid getting pregnant, you must use two forms of birth control while you're taking ambrisentan (Letairis) and for at least 1 month after the last dose. You'll also need to get monthly pregnancy tests during treatment. Contact your provider right away if you become pregnant while you're taking ambrisentan (Letairis).
No, ambrisentan (Letairis) tablets shouldn't be broken, split, or chewed. This could damage the medication and potentially affect how well ambrisentan (Letairis) works for you. Swallow ambrisentan (Letairis) tablets whole. Let your provider know if you're having trouble swallowing the tablets because you might need to be switched to a different medication.
Yes, you can take ambrisentan (Letairis) with or without food. There aren't any known food or drinks that interact with ambrisentan (Letairis) or affect how well ambrisentan (Letairis) works.
Ambrisentan (Letairis) and bosentan (Tracleer) are both endothelin receptor antagonists that are used for PAH. Studies show that they work just as well as each other. Both medications generally have similar side effects. But ambrisentan (Letairis) is more likely to cause swelling in the legs and feet, whereas bosentan (Tracleer) is more likely to cause liver problems. Unlike bosentan (Tracleer), ambrisentan (Letairis) can't be used in children because it hasn't been studied in this age group. Ambrisentan (Letairis) is taken once per day, whereas bosentan (Tracleer) is taken twice per day.
Talk to your provider about whether it's safe to drink alcohol while you're taking ambrisentan (Letairis). In general, you shouldn't drink alcohol while taking ambrisentan (Letairis) because this can raise your risk for side effects (e.g., low blood pressure, liver damage).
Ambrisentan (Letairis) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Ambrisentan (Letairis) shouldn't be taken during pregnancy because it can cause severe and life-threatening harm to unborn babies. Because of this risk, ambrisentan (Letairis) is available only through the Ambrisentan REMS program for females who can get pregnant. This Risk Evaluation and Mitigation Strategies (REMS) program helps make sure that the medication is as safe as possible for them.
If you're able to get pregnant, your provider will ask you take a pregnancy test before you start ambrisentan (Letairis), monthly during treatment, and once more a month after you stop the medication. You should use two forms of birth control during treatment with ambrisentan (Letairis) and for at least 1 month after completing treatment. Contact your provider right away if you become pregnant while taking ambrisentan (Letairis).
Ambrisentan (Letairis) can cause fluid buildup in the body, leading to swelling or shortness of breath. Fluid buildup can start to happen within weeks of starting ambrisentan (Letairis). If you have a history of heart failure, this fluid buildup can be severe and worsen your heart condition. Let your provider know before starting ambrisentan (Letairis) if you have any heart problems or heart failure. Contact your provider if you have any signs of heart failure, like shortness of breath; swelling in the legs, ankles, or feet; irregular heartbeat; not able to exercise; or tiredness, while you're taking ambrisentan (Letairis).
Ambrisentan (Letairis) might cause your hemoglobin levels to go down. In studies, a drop in hemoglobin levels happened within the first few weeks of starting ambrisentan (Letairis), but then stabilized throughout treatment. Hemoglobin is the protein on your red blood cells that carries oxygen to the rest of your body. Low hemoglobin levels can lead to anemia (low red blood cell count).
You'll need regular blood tests while you're taking ambrisentan (Letairis) so your provider can check your hemoglobin levels during treatment. If you have a history of anemia, speak with your provider before taking ambrisentan (Letairis) so they can make sure it's safe for you. Let your provider know if you experience symptoms of anemia, such as weakness, shortness of breath, dizziness, fast or irregular heartbeat, or pale skin, while you're taking ambrisentan (Letairis).
The typical starting dose is 5 mg by mouth once per day. After 4 weeks, your provider might raise your dose if needed. The maximum recommended dose is 10 mg per day.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Ambrisentan (Letairis) will not be safe for you to take.